Table 3.
Differentially expressed miRNAs among the MTC, benign nodule, and the healthy control groups by qRT-PCRa.
miRNA | MTC (n = 15) | Benign nodule (n = 15) | Healthy control (n = 15) | P valueb | P valuec | P valued |
---|---|---|---|---|---|---|
miR-222-3p | 0.731 ± 0.035 | 0.376 ± 0.066 | 0.253 ± 0.028 | <0.001 | <0.001 | 0.098 |
miR-17-5p | 2.719 ± 0.184 | 1.669 ± 0.322 | 1.079 ± 0.163 | <0.01 | <0.001 | 0.113 |
miR-451a | 0.803 ± 0.028 | 0.836 ± 0.043 | 0.629 ± 0.059 | 0.533 | <0.05 | <0.01 |
MTC: medullary thyroid carcinoma. aThe relative contents of miRNAs are normalized to let-7d/g/i and presented as mean ± SEM. bDifference between the MTC group and the benign nodule group. cDifference between the MTC group and the healthy control group. dDifference between the benign nodule group and the healthy control group.